spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  LAAC 

 HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 6 Sep 2022
Boston Scientific Receives FDA Approval for Expanded Labeling of WATCHMAN FLX(TM) LAAC Device for Dual Anti-Platelet Therapy as Post-Procedural Medication Option
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 6 Oct 2021
Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
Devices Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 25 Aug 2021
Baylis Medical Announces First Clinical Case Using the VersaCross(R) Large Access Solution in Canada
Devices Interventional Cardiology
 HSMN NewsFeed - 29 Oct 2020
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Mar 2019
Boston Scientific Receives CE Mark for Next Generation WATCHMAN FLX(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 2 Nov 2016
Boston Scientific Announces Initial U.S. Commercial Performance Of The WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Product Launch
 HSMN NewsFeed - 13 May 2016
Boston Scientific Announces Schedule of Presentations at EuroPCR 2016
Devices Interventional Cardiology
 HSMN NewsFeed - 8 Feb 2016
Boston Scientific Announces Medicare Will Cover WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 13 Mar 2015
Boston Scientific Receives FDA Approval for WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Cardiology FDA
 HSMN NewsFeed - 23 Oct 2012
Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami
Devices Interventional Cardiology
 HSMN NewsFeed - 11 May 2012
Study of First-in-Class WATCHMAN(R) Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy
Devices Interventional Cardiology
Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!